Methemoglobinemia - acquired

Acquired methemoglobinemia is a condition in which part of the hemoglobin in your blood changes into an abnormal form called methemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen from your lungs to the rest of your body.

Methemoglobin contains iron in a form that cannot carry oxygen normally. It also makes the remaining normal hemoglobin hold onto oxygen more tightly. As a result, your tissues may receive less oxygen even when your lungs are working properly.

Small amounts of methemoglobin are normally present and are quickly changed back into working hemoglobin. Acquired methemoglobinemia develops when a medicine, chemical, or other substance produces methemoglobin faster than your body can remove it.

Mild cases may cause few symptoms. Larger amounts can interfere with the brain, heart, and other organs. Recognizing the condition matters because a standard pulse oximeter may give a misleading reading, while a specific blood test can confirm the diagnosis.

Symptoms are influenced by the amount of methemoglobin, how quickly it developed, and your general health. People with anemia or heart or lung conditions may become unwell at lower levels.

Possible symptoms include:

• Blue, gray, or unusually dark coloring of the lips, tongue, skin, or nail beds
• Headache, tiredness, dizziness, or weakness
• Shortness of breath or a fast heartbeat
• Nausea, poor concentration, or confusion

The color change is called cyanosis. It may be harder to notice on some skin tones. Changes around the lips, tongue, gums, and nail beds may be more visible.

Severe methemoglobinemia can cause chest pain, abnormal heart rhythms, marked confusion, seizures, loss of consciousness, or collapse. These are emergency symptoms.

Symptoms do not always match a single methemoglobin level. The speed of exposure and any existing problems with oxygen delivery are also important.

Acquired methemoglobinemia happens after exposure to an oxidizing substance. This means a substance that chemically changes the iron in hemoglobin.

Medicines associated with the condition include the antibiotic like amoxicillin or doxycycline dapsone and some local anesthetics, especially benzocaine and prilocaine. Benzocaine may be found in certain mouth, throat, dental, or teething products. Exposure can also occur during medical procedures that use numbing sprays.

Other possible triggers include nitrates or nitrites, aniline dyes, nitrobenzene, and alkyl nitrites sometimes sold as “poppers.” Nitrate-contaminated private well water can be especially dangerous for young infants, including when it is used to prepare formula.

The risk may be higher after a large exposure, repeated applications, or use on damaged or inflamed tissue. However, the condition can occasionally occur after ordinary use of a product, particularly in someone who is more susceptible.

People with glucose-6-phosphate dehydrogenase deficiency, usually called G6PD deficiency, may respond differently to some oxidizing substances. Anemia and heart or lung conditions can make reduced oxygen delivery more serious.

Acquired methemoglobinemia is not contagious. It is different from rare inherited forms caused by changes in hemoglobin or in the enzymes that normally remove methemoglobin.

A health professional will consider recent medicines, dental or medical procedures, chemical exposure, recreational substances, and possible nitrate exposure. Bring product packaging or a medicine list if it is safe to do so.

The diagnosis is confirmed with co-oximetry, a blood test that directly measures different forms of hemoglobin, including methemoglobin. It can usually be performed on an arterial or venous blood sample.

A fingertip pulse oximeter cannot reliably diagnose this condition. Its reading may remain near the mid-80% range or may not improve as expected with oxygen. This pattern can raise suspicion, but it does not confirm the cause.

A standard blood gas test may show that the amount of oxygen dissolved in the blood is normal. This does not rule out methemoglobinemia because the problem is with hemoglobin carrying that oxygen.

Other tests may check your blood count, kidney and liver function, acid balance, or signs of red blood cell breakdown. Testing for G6PD deficiency may be considered when it could affect treatment.

The first step is to stop further exposure to the suspected substance. Do not make unsupervised changes to an essential prescription unless emergency services or a health professional advises you, but do stop using a nonessential topical or recreational product linked to new symptoms.

Treatment depends on your symptoms, methemoglobin level, the substance involved, and whether you have another condition that limits oxygen delivery.

Supplemental oxygen is often given. Oxygen does not directly remove methemoglobin, but it helps maximize the oxygen carried by the hemoglobin that is still working.

Methylene blue is an intravenous antidote used for significant methemoglobinemia. It helps the body change methemoglobin back into functioning hemoglobin. Treatment decisions require clinical monitoring because methylene blue is not suitable in every situation.

In people with G6PD deficiency, methylene blue may be less effective and can contribute to hemolysis, meaning destruction of red blood cells. It can also interact with medicines that increase serotonin, including some antidepressants like sertraline or fluoxetine, and may cause serotonin syndrome. The clinical team needs a complete medicine list before using it whenever circumstances allow.

Vitamin C, also called ascorbic acid, is sometimes considered when methylene blue cannot be used, but it generally acts more slowly. Severe cases that do not respond to initial treatment may require specialist measures such as exchange transfusion or hyperbaric oxygen therapy.

Some substances remain in the body for a long time. Dapsone, for example, can cause the methemoglobin level to rise again after initial improvement. Repeat blood tests and continued observation may therefore be necessary.

Most recognized and treated cases resolve without lasting effects. Complications become more likely when oxygen delivery is severely reduced or treatment is delayed.

Possible complications include abnormal heart rhythms, seizures, coma, injury to organs from low oxygen, and red blood cell breakdown. Severe untreated methemoglobinemia can be fatal, although this is not the usual outcome when the condition is identified and managed promptly.

The trigger itself may also cause poisoning or other organ damage unrelated to methemoglobin.

Many acquired cases can be prevented, but not every reaction is predictable.

Use medicines and numbing products only as directed. Do not apply more often, use larger amounts, or combine similar products unless instructed. The US Food and Drug Administration advises against using over-the-counter oral benzocaine products in children younger than 2 years.

Keep medicines, chemicals, fertilizers, and nitrite-containing products away from children. Follow workplace safety instructions when handling dyes, solvents, or industrial chemicals.

If infant formula is prepared with private well water, the water should be tested for nitrates. Boiling does not remove nitrate and may increase its concentration as water evaporates.

Tell health professionals about a previous episode before receiving local anesthetics or other possible triggers. If you know that you have G6PD deficiency, make sure this is recorded in your medical information.

Acquired methemoglobinemia is usually a short-term condition. Once the trigger is removed and methemoglobin is converted back to normal hemoglobin, oxygen delivery improves. Recovery may be rapid after effective treatment, but the timing depends on the substance and the severity of exposure.

Long-acting medicines can cause symptoms or abnormal blood results to return. You may need observation and repeated co-oximetry until the level remains stable. Follow-up may also include checking for anemia or red blood cell breakdown.

A brief episode that is treated before severe oxygen deprivation usually does not become a chronic condition. Lasting problems are more likely only after a severe episode that caused organ injury.

Before leaving care, you should know the suspected trigger, whether it needs to be avoided permanently, and whether alternative medicines are available. Keep the name of the substance in your health record. If no clear exposure was found or episodes happen again, further assessment may be needed to look for an inherited form or an unrecognized ongoing exposure.

Call emergency services now if you or someone else has blue or gray lips or skin together with breathing difficulty, chest pain, confusion, a seizure, fainting, extreme drowsiness, or collapse.

Get urgent assessment after a suspected medicine or chemical exposure if there is a new blue-gray color, persistent shortness of breath, severe headache, unusual weakness, or a low pulse oximeter reading that does not improve as expected. Do not rely on a home pulse oximeter to decide that the condition is safe.

Move away from fumes or chemicals if this can be done without entering a dangerous area. Do not make yourself vomit or give a home antidote. In the United States, Poison Control is available at 1-800-222-1222. Elsewhere, contact your local poison information service.

Routine follow-up is appropriate after recovery to review the suspected trigger, repeat blood tests if advised, and update your medicine record. Arrange a non-emergency appointment if fatigue persists, symptoms return, or you are uncertain whether a prescribed medicine should be continued.

Can acquired methemoglobinemia go away?

Yes. Most cases resolve after the triggering substance is removed, either through the body’s own repair systems or with treatment. Long-acting substances may require longer monitoring, and severe oxygen deprivation can affect recovery.

Will a pulse oximeter show methemoglobinemia?

Not reliably. A pulse oximeter may give a persistently low or unusual reading, often without matching the amount of oxygen dissolved in the blood. Co-oximetry is needed to confirm methemoglobinemia.

Why does oxygen not always correct the pulse oximeter reading?

Oxygen increases the amount available in the lungs and blood, but it does not immediately change methemoglobin back into working hemoglobin. The pulse oximeter may also misread methemoglobin. Oxygen is still useful as supportive treatment.

Is acquired methemoglobinemia inherited?

No. The acquired form results from exposure to a medicine or chemical. Rare inherited forms exist, and an inherited enzyme difference such as G6PD deficiency may affect susceptibility or treatment without being the direct cause of every episode.

Can benzocaine really cause it?

Yes. Benzocaine sprays, gels, and liquids have been linked to methemoglobinemia, including after use in the mouth or throat. Risk is not determined only by the amount used, so new cyanosis or breathing symptoms need urgent assessment.

Can methemoglobinemia come back after treatment?

It can. Some substances are absorbed slowly, remain in the body, or are converted into active breakdown products. Dapsone is a well-known cause of recurrence. Continued observation and repeat blood testing may be needed.